Jan Frystyk

Head of Department and Professor

Odense University Hospital

Denmark

Research Interests

Contact this professor

Get a free first email built on one of their papers, ready for you to edit and send yourself.

About

Jan Frystyk is the Head of Department and Professor at Odense Universitets Hospital in Denmark. His research focuses on endocrinology, obesity, and metabolic disorders, as highlighted in his recent articles that explore topics such as growth hormone deficiency, leptin concentrations in obese individuals, and insulin sensitivity in type 2 diabetes. He has also investigated the implications of liver conditions and quality of life in patients with a history of illicit androgen use.

Articles (10)

Year:

2025

Year:

2025

Year:

2025

Year:

2025

Year:

2024

Year:

2024

Year:

2024

Year:

2023

Year:

2023

Year:

2023

Collaborators (9)

Jørgen Jeppesen

Professor

University of Copenhagen

DENMARK

View details

Signe Borgquist

Aarhus University

DENMARK

View details

Rikke Hjortebjerg

University of Southern Denmark

DENMARK

View details

Anders K. Lemminger

Københavns Universitet

DENMARK

View details

Caroline Kistorp

Professor

Rigshospitalet

DENMARK

View details

Jon Jarløv Rasmussen

Copenhagen University Hospital

DENMARK

View details

Peer Christiansen

Professor

Aarhus University Hospital

DENMARK

View details

Faidon Magkos

Københavns Universitet

DENMARK

View details

Ho-Seong Kim

Professor

Severance Hospital

SOUTH KOREA

View details

ApplyKite TwinLearns as you apply

Make your next move.

Prepare your application

Review drafts before you send them.

Jan Frystyk

Research Interests

Contact this professor

About

Articles (10)

Obese Hypertensive Men Have Fasting Serum Concentrations of Leptin Similar to Those of Obese Normotensive Men

Efficacy, safety, and insulin-like growth factor I of weekly somapacitan in children with growth hormone deficiency: 3-year results from REAL4

Characterization of Leydig Cell Dysfunction in Previous Illicit Androgen Users

Acute hepatic porphyria in Denmark; a retrospective study

Circulating C-reactive protein levels as a prognostic biomarker in breast cancer across body mass index groups

Effect of a 6-Week Carbohydrate-Reduced High-Protein Diet on Levels of FGF21 and GDF15 in People With Type 2 Diabetes

Somapacitan in Children Born SGA: 52-Week Efficacy, Safety, and IGF-I Response Results From the Phase 2 REAL5 Study

Persistently decreased quality of life and its determinants in previous illicit androgen users

Associations between insulin-like growth factor binding protein-2 and insulin sensitivity, metformin, and mortality in persons with T2D

Markers of Glucagon Resistance Improve With Reductions in Hepatic Steatosis and Body Weight in Type 2 Diabetes

Collaborators (9)

Jørgen Jeppesen

Signe Borgquist

Rikke Hjortebjerg

Anders K. Lemminger

Caroline Kistorp

Jon Jarløv Rasmussen

Peer Christiansen

Faidon Magkos

Ho-Seong Kim

Make your next move.